132 related articles for article (PubMed ID: 717986)
1. Sequential carcinoembryonic antigen levels in the therapy of metastatic breast cancer: a predictor and monitor of response and relapse.
Lokich JJ; Zamcheck N; Lowenstein MW
Ann Intern Med; 1978 Dec; 89(6):902-6. PubMed ID: 717986
[TBL] [Abstract][Full Text] [Related]
2. Prospective evaluation of carcinoembryonic antigen levels and alternating chemotherapeutic regimens in metastatic breast cancer.
Loprinzi CL; Tormey DC; Rasmussen P; Falkson G; Davis TE; Falkson HC; Chang AY
J Clin Oncol; 1986 Jan; 4(1):46-56. PubMed ID: 3510282
[TBL] [Abstract][Full Text] [Related]
3. Carcinoembryonic antigen in patients with breast cancer: an adjunctive tool to monitor response and therapy.
Falkson HC; Van Der Watt JJ; Portugal MA; Pitout MJ; Falkson G
Cancer; 1978 Sep; 42(3):1308-13. PubMed ID: 698917
[TBL] [Abstract][Full Text] [Related]
4. Quantitation of response to therapy in patients with metastatic breast carcinoma by serial analysis of plasma gross cystic disease fluid protein and carcinoembryonic antigen.
Silva JS; Leight GS; Haagensen DE; Tallos PB; Cox EB; Dilley WG; Wells SA
Cancer; 1982 Mar; 49(6):1236-42. PubMed ID: 6174201
[TBL] [Abstract][Full Text] [Related]
5. Serial plasma carcinoembryonic antigen measurements during treatment of metastatic breast cancer.
Mughal AW; Hortobagyi GN; Fritsche HA; Buzdar AU; Yap HY; Blumenschein GR
JAMA; 1983 Apr; 249(14):1881-6. PubMed ID: 6834584
[TBL] [Abstract][Full Text] [Related]
6. Serial plasma carcinoembryonic antigen measurements in the management of metastatic colorectal carcinoma.
Shani A; O'Connell MJ; Moertel CG; Schutt AJ; Silvers A; Go VL
Ann Intern Med; 1978 May; 88(5):627-30. PubMed ID: 646245
[TBL] [Abstract][Full Text] [Related]
7. Serial carcinoembryonic antigen (CEA) determinations in the management of patients with breast cancer.
Staab HJ; Ahlemann LM; Koch HL; Anderer FA
Oncodev Biol Med; 1980; 1(3):151-60. PubMed ID: 7279702
[TBL] [Abstract][Full Text] [Related]
8. Criteria for monitoring carcinoembryonic antigen: variability of sequential assays at elevated levels.
Lokich JJ; Ellenberg S; Gerson B
J Clin Oncol; 1984 Mar; 2(3):181-6. PubMed ID: 6699670
[TBL] [Abstract][Full Text] [Related]
9. Serial plasma carcinoembryonic antigen measurement for monitoring patients with advanced lung cancer during chemotherapy.
Shinkai T; Saijo N; Tominaga K; Eguchi K; Shimizu E; Sasaki Y; Fujita J; Futami H; Ohkura H; Suemasu K
Cancer; 1986 Apr; 57(7):1318-23. PubMed ID: 3004689
[TBL] [Abstract][Full Text] [Related]
10. Biological markers in breast carcinoma. III. Clinical correlations with carcinoembryonic antigen.
Tormey DC; Waalkes TP; Snyder JJ; Simon RM
Cancer; 1977 Jun; 39(6):2397-404. PubMed ID: 872038
[TBL] [Abstract][Full Text] [Related]
11. Serial carcinoembryonic antigen (CEA) determinations in the management of metastatic breast cancer.
Lamerz R; Leonhardt A; Ehrhart H; von Lieven H
Oncodev Biol Med; 1980; 1(2):123-35. PubMed ID: 7279699
[TBL] [Abstract][Full Text] [Related]
12. [Carcinoembryonic antigens (CEA) in patients with metastatic breast cancer under endocrine and therapeutic treatment (author's transl)].
Pompecki R; Schröder G; Garbrecht M; Frahm H
Dtsch Med Wochenschr; 1978 Apr; 103(14):620-2. PubMed ID: 639696
[TBL] [Abstract][Full Text] [Related]
13. [Determination of the carcinoembryonic antigen (CEA) for predicting the success of therapy in metastatic breast cancer].
Krieger G; Wander HE; Prangen M; Bandlow G; Beyer JH; Nagel GA
Dtsch Med Wochenschr; 1983 Apr; 108(16):610-4. PubMed ID: 6839982
[TBL] [Abstract][Full Text] [Related]
14. [Diagnostic validity of CEA determination in metastasizing breast cancer].
Krieger G; Prangen M; Klar R; Kneba M; Bandlow G; Nagel GA
Klin Wochenschr; 1986 Aug; 64(15):701-7. PubMed ID: 3762017
[TBL] [Abstract][Full Text] [Related]
15. Serial tests of carcinoembryonic antigen in patients with breast cancer.
Lee YT
Am J Clin Oncol; 1983 Jun; 6(3):287-93. PubMed ID: 6846246
[TBL] [Abstract][Full Text] [Related]
16. The value of serial plasma levels of carcinoembryonic antigen and gross cyst disease fluid protein in patients with breast carcinoma and osseous metastases.
Haagensen DE; Barry WF; McCook TA; Giannola J; Ammirata S; Wells SA
Ann Surg; 1980 May; 191(5):599-603. PubMed ID: 7369822
[TBL] [Abstract][Full Text] [Related]
17. Human tissue polypeptide antigen in breast cancer.
Nemoto T; Constantine R; Chu TM
J Natl Cancer Inst; 1979 Dec; 63(6):1347-50. PubMed ID: 292806
[TBL] [Abstract][Full Text] [Related]
18. Metastatic breast cancer with constantly low CEA blood levels. A subgroup with unfavorable prognosis?
Krieger G; Wander HE; Kneba M; Prangen M; Bandlow G; Nagel GA
J Cancer Res Clin Oncol; 1984; 108(3):341-4. PubMed ID: 6511807
[TBL] [Abstract][Full Text] [Related]
19. Sequential carcinoembryonic antigen levels. A predictor of response and relapse in combination chemotherapy of advanced gastrointestinal cancer.
Ichiki AT; Krauss S; Israelsen KL; Sonoda T; Collmann IR
Oncology; 1981; 38(1):27-30. PubMed ID: 7443173
[TBL] [Abstract][Full Text] [Related]
20. Comparison of circulating CA15-3 and carcinoembryonic antigen levels in patients with breast cancer.
Hayes DF; Zurawski VR; Kufe DW
J Clin Oncol; 1986 Oct; 4(10):1542-50. PubMed ID: 2428949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
